CD20 monoclonal antibodies
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. The complex can be recognized and destroyed by phagocytes or used for other diagnostic purposes.
Natural antibodies are proteins made by the B-lymphocytes in response to antigens. Each B-cell makes only one type of antibody. For therapeutic purposes a significant amount of a particular antibody is needed. These are obtained from a culture that gives a one type of antibody, which are called monoclonal antibodies.
CD20 monoclonal antibodies are targeted against B-cell antigens, and are used in the treatment of B-cell Non-Hodgkin
Drug Name  ( View by: Brand | Generic )
|
Reviews | Avg. Ratings |
|
|---|---|---|---|
| ofatumumab systemic (Pro, More...) |
0 Review(s) | Rate It! | 9.0 |
| rituximab systemic (Pro, More...) |
15 Review(s) | Rate It! | 8.2 |
| ibritumomab systemic (Pro, More...) |
0 Review(s) | Rate It! | 0.0 |
| iodine i 131 tositumomab systemic (Pro, More...) |
0 Review(s) | Rate It! | 0.0 |
| tositumomab systemic (Pro, More...) |
0 Review(s) | Rate It! | 0.0 |
See also
Medical conditions associated with CD20 monoclonal antibodies:
